nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Approaches to informed consent
|
Tognoni, Gianni |
|
1997 |
18 |
6 |
p. 621-627 7 p. |
artikel |
2 |
Author index for volume 18
|
|
|
1997 |
18 |
6 |
p. 667-668 2 p. |
artikel |
3 |
Clinical perspectives on the use of composite endpoints
|
Cannon, Christopher P. |
|
1997 |
18 |
6 |
p. 517-529 13 p. |
artikel |
4 |
Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretation
|
Pocock, Stuart J. |
|
1997 |
18 |
6 |
p. 530-545 16 p. |
artikel |
5 |
Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis
|
Pogue, Janice M. |
|
1997 |
18 |
6 |
p. 580-593 14 p. |
artikel |
6 |
Developing systems for cost-effective auditing of clinical trials
|
Califf, Robert M. |
|
1997 |
18 |
6 |
p. 651-660 10 p. |
artikel |
7 |
Discussion: Errors, misunderstandings and fraud
|
Williams, George W. |
|
1997 |
18 |
6 |
p. 661-666 6 p. |
artikel |
8 |
Discussion: On the role and analysis of secondary outcomes in clinical trials
|
Prentice, Ross L. |
|
1997 |
18 |
6 |
p. 561-567 7 p. |
artikel |
9 |
Discussion: Some issues in the construction and use of clusters of outcome events
|
Gent, Michael |
|
1997 |
18 |
6 |
p. 546-549 4 p. |
artikel |
10 |
Discussion: Why clinical trials in the evaluation of life style evaluation?
|
Knatterud, Genell L. |
|
1997 |
18 |
6 |
p. 514-516 3 p. |
artikel |
11 |
Distinctions between fraud, bias, errors, misunderstanding, and incompetence
|
DeMets, David L. |
|
1997 |
18 |
6 |
p. 637-650 14 p. |
artikel |
12 |
Individual subject random assignment is the preferred means of evaluating behavioral lifestyle modification
|
Terrin, Michael L. |
|
1997 |
18 |
6 |
p. 500-505 6 p. |
artikel |
13 |
Influence of study goals on study design and execution
|
Kirklin, John W. |
|
1997 |
18 |
6 |
p. 488-493 6 p. |
artikel |
14 |
Informed consent: Protection or obstacle? Some emerging issues
|
Ellenberg, Susan S. |
|
1997 |
18 |
6 |
p. 628-636 9 p. |
artikel |
15 |
Introduction
|
Yusuf, Salim |
|
1997 |
18 |
6 |
p. 477- 1 p. |
artikel |
16 |
Meta-analysis of randomized trials: Looking back and looking ahead
|
Yusuf, Salim |
|
1997 |
18 |
6 |
p. 594-601 8 p. |
artikel |
17 |
Observational epidemiology is the preferred means of evaluating effects of behavioral and lifestyle modification
|
Stampfer, Meir |
|
1997 |
18 |
6 |
p. 494-499 6 p. |
artikel |
18 |
Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance
|
Davis, C.E. |
|
1997 |
18 |
6 |
p. 557-560 4 p. |
artikel |
19 |
Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance
|
O'Neill, Robert T. |
|
1997 |
18 |
6 |
p. 550-556 7 p. |
artikel |
20 |
Strengths and limitations of meta-analysis: Larger studies may be more reliable
|
Flather, Marcus D. |
|
1997 |
18 |
6 |
p. 568-579 12 p. |
artikel |
21 |
Subject index for volume 18
|
|
|
1997 |
18 |
6 |
p. 669-682 14 p. |
artikel |
22 |
Surgical procedures and devices should be evaluated in the same way as medical therapy
|
Buchwald, Henry |
|
1997 |
18 |
6 |
p. 478-487 10 p. |
artikel |
23 |
The advantages of community-randomized trials for evaluating lifestyle modification
|
Green, Sylvan B. |
|
1997 |
18 |
6 |
p. 506-513 8 p. |
artikel |
24 |
Volume contents
|
|
|
1997 |
18 |
6 |
p. I-V nvt p. |
artikel |
25 |
When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?
|
Temple, Robert J. |
|
1997 |
18 |
6 |
p. 613-620 8 p. |
artikel |
26 |
When are placebo-controlled trials no longer appropriate?
|
Brody, Baruch A. |
|
1997 |
18 |
6 |
p. 602-612 11 p. |
artikel |